HSBC Holdings
NUVB icon

HSBC Holdings’s Nuvation Bio NUVB Stock Holding History

HSBC Holdings’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$101K Buy
+23,724
New +$132K ﹤0.01% 2751
2025
Q4 		– Sell
-211,294
Closed -$815K – 3090
2025
Q3 		$815K Sell
211,294
-67,636
-24% -$184K ﹤0.01% 1883
2025
Q2 		$547K Buy
278,930
+89,271
+47% +$186K ﹤0.01% 2106
2025
Q1 		$326K Buy
189,659
+46,436
+32% +$106K ﹤0.01% 2328
2024
Q4 		$378K Buy
143,223
+25,870
+22% +$66.6K ﹤0.01% 2347
2024
Q3 		$277K Sell
117,353
-15,955
-12% -$48.7K ﹤0.01% 2409
2024
Q2 		$425K Sell
133,308
-58,233
-30% -$178K ﹤0.01% 2067
2024
Q1 		$697K Buy
191,541
+16,597
+9% +$31.9K ﹤0.01% 1935
2023
Q4 		$262K Buy
174,944
+117
+0.1% +$151 ﹤0.01% 2346
2023
Q3 		$238K Buy
174,827
+62,844
+56% +$105K ﹤0.01% 2333
2023
Q2 		$200K Buy
111,983
+12,540
+13% +$21.3K ﹤0.01% 2325
2023
Q1 		$165K Buy
99,443
+17,413
+21% +$35.3K ﹤0.01% 2428
2022
Q4 		$154K Buy
82,030
+53,941
+192% +$109K ﹤0.01% 2831
2022
Q3 		$66K Buy
+28,089
New +$80.2K ﹤0.01% 2798
2021
Q3 		– Sell
-10,587
Closed -$98K – 3109
2021
Q2 		$98K Buy
+10,587
New +$121K ﹤0.01% 2851

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HSBC Holdings's NUVB Position: Q1 2026 in Review

HSBC Holdings opened a new position in Nuvation Bio (NUVB) in Q1 2026: 23,724 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #2751 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in NUVB as recently as Q3 2025.

HSBC Holdings first reported a position in NUVB in Q2 2021 and has held it in 15 quarters since. The position peaked at $815K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • HSBC Holdings held 23,724 shares of Nuvation Bio worth $101K as of Q1 2026.
  • Nuvation Bio was a new HSBC Holdings position in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2751 holding.
  • HSBC Holdings first reported a position in Nuvation Bio in Q2 2021 and has held it in 15 quarters since.
  • HSBC Holdings's Nuvation Bio position peaked at $815K in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.